SUBSCRIBE
SUBSCRIBE
News   Job Trends

Organon Takeover Too Costly and Complicated, Says Merck & Co., Inc.; Merck Plans to Close R&D and Production Line with the Loss of Over 2,000 Jobs

March 7, 2011 | 
1 min read

Dutch News -- US pharmaceuticals giant Merck turned down an offer for its Organon unit in Oss because it would cost the company $700m more than closing it down, the company told a court hearing on Friday.

Job creations Europe
Merck & Co. Organon
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Cellectar Downsizes by 60% as it Explores Strategic Options for Cancer Drug
December 11, 2024
 · 
202 min read
 · 
BioSpace Editorial Staff
Sign outside BioNTech's building in Germany
Breast cancer
BioNTech Builds Case for PD-L1/VEGF Bispecific With Promising Breast Cancer Data
December 11, 2024
 · 
2 min read
 · 
Tristan Manalac
Group Of Employees Being Fired By Their Company.
Layoffs
Carisma Therapeutics to Cut 34% of Staff, Reprioritize Pipeline
December 10, 2024
 · 
2 min read
 · 
Angela Gabriel
A handshake of businessmen. Modern design with a positive context. Concept of help, support, and agreement between businessmen. Modern art collage, trendy magazine style.
Mergers & acquisitions
Novo, Catalent $16.5B Deal Wins EU Blessing as US Antitrust Scrutiny Mounts
December 9, 2024
 · 
2 min read
 · 
Tristan Manalac